Innovations Spotlight

Lifelong Innovation: The TMAO Story

08/05/2019

Lifelong Innovation: The TMAO Story

A member of Cleveland Clinic’s staff since 1997, Stanley Hazen, MD, PhD, is both a practicing physician and researcher with many leadership roles. He has published over 400 peer-reviewed manuscripts and is counted amongst some of the most highly cited investigators in the country – attesting to the high impact his studies have made. But his thirst for research has yet to be quenched.


Neighbors Helping Neighbors

08/02/2019

Neighbors Helping Neighbors

On Thursday, July 24, the staff of CCI took place in a day of service in partnership with Fairfax Renaissance Development Corporation (FRDC) to assist members of our community. Team members came together to help two wonderful neighbors work on the exterior of their homes, as well as the local park – including painting, staining decks, pruning and gardening, and mulching.  


Anesthesiologists Invent Device to Tackle the Problem of Airway Management

07/31/2019

Anesthesiologists Invent Device to Tackle the Problem of Airway Management

Drs. Rafi Avitsian and Andrew Zura are passionate about what they do and how they improve patient care. Both anesthesiologists at Cleveland Clinic, Dr. Avitsian is the program director for the Neuroanesthesiology Fellowship, and Dr. Zura is the section head for ENT Anesthesia. For these physicians, innovation means finding a way to improve airway management.


HDL Quality Over Quantity in Prediction of Major Adverse Cardiac Events

07/30/2019

HDL Quality Over Quantity in Prediction of Major Adverse Cardiac Events

Jonathan Smith, PhD, is the Geoffrey Gund Endowed Chair for Cardiovascular Research at Lerner Research Institute. With Cleveland Clinic since 2002, Smith has made major strides in his work toward cardiovascular excellence. Smith’s latest project involves an ApoA1 Exchange Rate Assay as a Diagnostic tool for Major Adverse Cardiovascular Events (MACE).


The Changing Role of Consumerization in Healthcare

07/29/2019

The Changing Role of Consumerization in Healthcare

Let’s face it: Patients are taking a greater role in their healthcare and are demanding more. More access to caregivers, more transparency, more data, more options. Today, we don’t have time to schedule an appointment for three months from now; we want to be seen in 30 minutes.


Ventures-Investment-Innovations Team Rides in Velosano

07/29/2019

Ventures-Investment-Innovations Team Rides in Velosano

Congratulations to all of the riders, volunteers and donors from the CC Ventures Investment Innovation Velosano team who took part in the ride for the cure over July 20-21. This was an impressive showing with nearly 100% participation from all three departments. We had 36 riders ride 2,032 miles over the weekend


Temporal Importance in the Reinvention of Radiation Therapy

07/18/2019

Temporal Importance in the Reinvention of Radiation Therapy

Jacob Scott, MD, DPhil, of Lerner Reserach Institute is not your average doctor. In his every day practice, Dr. SCott leverages a multi-dimensional background. From his time studying astrophysics and nuclear engineering while working aboard a submarine, he utilizes his expertise in computer science and mathematical biology to improve patient care. With two innovative technologies, Jacob looks to maximize radiation therapy efficacy and minimize toxicity in his patients.


O’Neill Testifies in Front of Senate Judiciary Committee

07/17/2019

O’Neill Testifies in Front of Senate Judiciary Committee

In early June in Washington, D.C., Cleveland Clinic Innovations (CCI) Executive Director Pete O’Neill testified in front of a Senate Judiciary Committee on the state of patent eligibility in America. One of 45 witnesses across three days of testimony, O’Neill spoke to Cleveland Clinic’s perspective on the importance of having confidence that an issued patent that follows guidance of the USPTO will not be invalidated based on court case-law.  His testimony addressed Cleveland Clinic’s experience with patenting the diagnostic MPO test, which led to the creation of Cleveland HeartLab. Specifically, he spoke about cases before federal district courts whereby the court rulings resulted in losing the protection of the MPO patents.


AI and the Evolving Nature of Drug Discovery

07/11/2019

AI and the Evolving Nature of Drug Discovery

In turning molecules into medicines, most studies report success 1 out of 10 tries. Yet rapid discovery and development of safe, effective drugs is crucial to moving the needle in healthcare. With unlimited chemical combinations, discovering new candidate medicines is a lengthy, intricate process. Post discovery, drug development is also slow. Undoubtedly, medications require careful progression from bench to bedside to prevent oversight and harm in the ultimate consumers. But with the goal of breakthrough treatments for all conditions, trending HIT applications just might get equally safe medication to the hands of patients sooner. 


Using 6 Clicks to Improve Mobility

07/02/2019

Using 6 Clicks to Improve Mobility

At the hospital, patients often think they will stay in bed, rest and heal. However, after all that rest, strength and mobility can decrease and patients often aren’t as ready to go home as they thought. Five years ago, when therapy leaders at Cleveland Clinic had the chance to collect basic patient data, they felt a functional measure would be most impactful to their work.  But there was nothing appropriate on the market, so they created it themselves. They worked with Boston University to produce inpatient short forms for the Activity Measure for Post-Acute Care or AM-PAC. AM-PAC, and the 6 Clicks training materials, are an example of how our Adeo platform can help reduce barriers to bring products to market. 


 <  1 2 3 4 5 6 7 8 9 10  > 

Get In Touch With Us